StemGenn Therapeutics
New Delhi, India· Est.
Indian cellular‑therapy company offering autologous stem‑cell treatments for fertility, urology and anti‑aging.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian cellular‑therapy company offering autologous stem‑cell treatments for fertility, urology and anti‑aging.
Regenerative MedicineFertilityUrologyOrthopedicsAesthetic Medicine
Technology Platform
Autologous cell‑based therapies using mesenchymal stem cells, adipose‑derived cells (Lipokraft™) and proprietary O‑Cell® processing to regenerate damaged tissues.
Opportunities
Rapid expansion of franchise clinics across India and Asia, and rising consumer demand for regenerative and anti‑aging therapies.
Risk Factors
Regulatory uncertainty, need for robust clinical evidence, and intense competition from other stem‑cell service providers.
Competitive Landscape
Competes with Indian cell‑therapy firms such as Stempeutics and Rejuvenate; differentiation relies on proprietary Lipokraft™/O‑Cell® platforms and extensive training/education ecosystem.